N-(2-Cyclopropylethyl)-6-(4-(3,3,3-trifluoro-2-methyl-2-(trifluoromethyl)propanoyl)piperazin-1-yl)pyridazine-3-carboxamide

ID: ALA2315118

PubChem CID: 11442719

Max Phase: Preclinical

Molecular Formula: C19H23F6N5O2

Molecular Weight: 467.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C(=O)N1CCN(c2ccc(C(=O)NCCC3CC3)nn2)CC1)(C(F)(F)F)C(F)(F)F

Standard InChI:  InChI=1S/C19H23F6N5O2/c1-17(18(20,21)22,19(23,24)25)16(32)30-10-8-29(9-11-30)14-5-4-13(27-28-14)15(31)26-7-6-12-2-3-12/h4-5,12H,2-3,6-11H2,1H3,(H,26,31)

Standard InChI Key:  OXYOAVSPJRYTSY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
    2.9279   -5.2299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7451   -5.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1543   -4.5232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9715   -4.5238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3806   -3.8164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1978   -3.8171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9726   -3.1084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6034   -4.5237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4198   -4.5247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8298   -3.8168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4173   -3.1064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6022   -3.1089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6473   -3.8178    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0550   -4.5271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8687   -4.5286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2807   -3.8225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8729   -3.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0532   -3.1101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0979   -3.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5042   -4.5342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5088   -3.1188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2179   -4.8201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2172   -5.6373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0933   -5.2406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0804   -3.9498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0804   -5.1095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8633   -3.1619    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.8976   -3.9498    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6582   -3.3678    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.8695   -5.8990    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.8696   -4.8974    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6582   -5.6873    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  6  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 10 13  1  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
 22  1  1  0
 23 22  1  0
  1 23  1  0
 20 24  1  0
 20 25  1  0
 20 26  1  0
 25 27  1  0
 25 28  1  0
 25 29  1  0
 26 30  1  0
 26 31  1  0
 26 32  1  0
M  END

Associated Targets(Human)

Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCD Tchem Acyl-CoA desaturase (1011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Fads1 Fatty acid desaturase 1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Scd1 Acyl-CoA desaturase 1 (352 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.41Molecular Weight (Monoisotopic): 467.1756AlogP: 2.79#Rotatable Bonds: 6
Polar Surface Area: 78.43Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.61CX LogP: 2.69CX LogD: 2.69
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.65Np Likeness Score: -1.55

References

1. Zhang Z, Sun S, Kodumuru V, Hou D, Liu S, Chakka N, Sviridov S, Chowdhury S, McLaren DG, Ratkay LG, Khakh K, Cheng X, Gschwend HW, Kamboj R, Fu J, Winther MD..  (2013)  Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.,  56  (2): [PMID:23245208] [10.1021/jm301661h]

Source